- recruitingPHASE3
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
This study looks at a new medicine for agitation in people with Alzheimer's. It aims to see if an experimental drug, given as capsules, is safe and works well over a long time for those who've been in similar studies before.
United States · Argentina · Brazil - authorisedTherapeutic exploratory (Phase II)
A Randomized Open-Label, Parallel-Group, Phase 2, 2-Arm Study to Investigate the Pharmacokinetic Profiles of Midazolam Subcutaneous Injection Compared with Midazolam Intravenous Injection in Adult Male and Female Terminally Ill Patients
This study compares two ways of giving a medicine called midazolam to people with difficult symptoms at the end of their lives. It looks at how the body handles the medicine when given as an injection under the skin versus directly into a vein.
Norway